Detalles de la búsqueda
1.
Vaccine escape, increased breakthrough and reinfection in infliximab-treated patients with IBD during the Omicron wave of the SARS-CoV-2 pandemic.
Gut
; 72(2): 295-305, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35902214
2.
Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic.
Gut
; 71(7): 1426-1439, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35477864
3.
Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD.
Gut
; 70(10): 1884-1893, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33903149
4.
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab.
Gut
; 70(5): 865-875, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33753421
5.
Baseline Expression of Immune Gene Modules in Blood is Associated With Primary Response to Anti-TNF Therapy in Crohn's Disease Patients.
J Crohns Colitis
; 18(3): 431-445, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37776235
6.
Naive pluripotent stem cell-based models capture FGF-dependent human hypoblast lineage specification.
Cell Stem Cell
; 2024 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38823388
7.
Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study.
Lancet Gastroenterol Hepatol
; 9(6): 521-538, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38640937
8.
Anti-TNF Biologicals Enhance the Anti-Inflammatory Properties of IgG N-Glycome in Crohn's Disease.
Biomolecules
; 13(6)2023 06 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37371534
9.
Pretreatment Vitamin D Concentrations Do Not Predict Therapeutic Outcome to Anti-TNF Therapies in Biologic-Naïve Patients With Active Luminal Crohn's Disease.
Crohns Colitis 360
; 5(3): otad026, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37265586
10.
Baseline TREM-1 Whole Blood Gene Expression Does Not Predict Response to Adalimumab Treatment in Patients with Ulcerative Colitis or Crohn's Disease in the SERENE Studies.
J Crohns Colitis
; 2023 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37801628
11.
Whole blood DNA methylation changes are associated with anti-TNF drug concentration in patients with Crohn's disease.
J Crohns Colitis
; 2023 Aug 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37551994
12.
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study.
Lancet Gastroenterol Hepatol
; 8(2): 145-156, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36481043
13.
The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patients.
EBioMedicine
; 88: 104430, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36634565
14.
Nitrogen concentration acting as an environmental signal regulates cyanobacterial EPS excretion.
Chemosphere
; 291(Pt 2): 132878, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34780741
15.
Understanding anti-TNF treatment failure: does serum triiodothyronine-to-thyroxine (T3/T4) ratio predict therapeutic outcome to anti-TNF therapies in biologic-naïve patients with active luminal Crohn's disease?
Aliment Pharmacol Ther
; 56(5): 783-793, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35768996
16.
Patient-led Remote IntraCapillary pharmacoKinetic Sampling (fingerPRICKS) for Therapeutic Drug Monitoring in patients with Inflammatory Bowel Disease.
J Crohns Colitis
; 16(2): 190-198, 2022 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34289028
17.
Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients.
J Crohns Colitis
; 16(3): 389-397, 2022 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34473254
18.
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab.
Nat Commun
; 13(1): 1379, 2022 03 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35296643
19.
Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring study.
Aliment Pharmacol Ther
; 56(8): 1250-1263, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36039036
20.
Root-cause analyses of missed opportunities for the diagnosis of colorectal cancer in patients with inflammatory bowel disease.
Aliment Pharmacol Ther
; 53(2): 291-301, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33159472